Nonetheless, our finding that prognostic significance of S100A8+ ICs depends on HR status gives an important clue to the role of S100A8+ ICs in breast cancer progression since HR-positive tumors are generally less immunogenic compared to HR-positive tumors. Here, S100A8 is linked to breast carcinoma.